Application of PET/CT in Diagnosis and Treatment of Cancers
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Medical Imaging and Theranostics".
Deadline for manuscript submissions: 31 October 2024 | Viewed by 77
Special Issue Editor
Special Issue Information
Dear Colleagues,
PET/CT technology is a medical imaging technique that combines positron emission tomography (PET) and computed tomography (CT) to simultaneously provide functional and anatomical information. It has significant application value in cancer diagnosis and treatment.
On one hand, PET/CT can accurately locate a tumor’s position, size, and metastasis. Because PET/CT can detect metabolic activity in tumors, it has high sensitivity and specificity for early-stage tumors that are difficult to detect using conventional imaging techniques, such as lung cancer and lymphoma. On the other hand, PET/CT plays an important role in evaluating the therapeutic effect of tumors and adjusting treatment plans. By comparing the results of PET/CT scans before and after treatment, doctors can determine whether the tumor has responded to treatment and whether the treatment plan needs to be adjusted. In addition, PET/CT can also be used to look for signs of tumor recurrence and monitor the patient's condition changes.
18F-FDG is the commonly used tracer for PET imaging and has a wide range of applications in the diagnosis of various tumors. Other innovative tracers, such as fibroblast activation protein inhibitor (FAPI) or prostate-specific membrane antigen (PSMA), labeled with Gallium-68 or Fluor-18, can be complementary with 18F-FDG or be very accurate alone in certain types of tumors. In this Special Issue, we hope to show the latest progress in the application of various tracers in tumor diagnosis and treatment. We look forward to your submissions and participation in this exciting Special Issue.
Dr. Alberto Miceli
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- PET/CT
- 18F-FDG
- cancers
- diagnosis
- cancer treatment
Planned Papers
The below list represents only planned manuscripts. Some of these manuscripts have not been received by the Editorial Office yet. Papers submitted to MDPI journals are subject to peer-review.
